Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 25101-1-AP - Provider product page

- Provider
- Proteintech Group
- Product name
- WFDC12 antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated WFDC12 antibody (Cat. #25101-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: IHC,ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references WFDC12-overexpressing contributes to the development of atopic dermatitis via accelerating ALOX12/15 metabolism and PAF accumulation.
A role for whey acidic protein four-disulfide-core 12 (WFDC12) in the pathogenesis and development of psoriasis disease.
The Whey Acidic Protein WFDC12 Is Specifically Expressed in Terminally Differentiated Keratinocytes and Regulates Epidermal Serine Protease Activity.
Li G, Gu L, Zhao F, Hu Y, Wang X, Zeng F, Yu J, Yue C, Zhou P, Li Y, Feng Y, Hu J, Huang N, Wu W, Cui K, Li W, Li J
Cell death & disease 2023 Mar 8;14(3):185
Cell death & disease 2023 Mar 8;14(3):185
A role for whey acidic protein four-disulfide-core 12 (WFDC12) in the pathogenesis and development of psoriasis disease.
Zhao F, Zhang C, Li G, Zheng H, Gu L, Zhou H, Xiao Y, Wang Z, Yu J, Hu Y, Zeng F, Wang X, Zhao Q, Hu J, Yue C, Zhou P, Huang N, Hao Y, Wu W, Cui K, Li W, Li J
Frontiers in immunology 2022;13:873720
Frontiers in immunology 2022;13:873720
The Whey Acidic Protein WFDC12 Is Specifically Expressed in Terminally Differentiated Keratinocytes and Regulates Epidermal Serine Protease Activity.
Kalinina P, Vorstandlechner V, Buchberger M, Eckhart L, Lengauer B, Golabi B, Laggner M, Hiess M, Sterniczky B, Födinger D, Petrova E, Elbe-Bürger A, Beer L, Hovnanian A, Tschachler E, Mildner M
The Journal of investigative dermatology 2021 May;141(5):1198-1206.e13
The Journal of investigative dermatology 2021 May;141(5):1198-1206.e13
No comments: Submit comment
No validations: Submit validation data